Canopy Growth Corp Transfers 1,500 Cannabis Clones to Spain for Madrid Based Operations | CashCropToday
0 Shares 123 Views

Canopy Growth Corp Transfers 1,500 Cannabis Clones to Spain for Madrid Based Operations

March 19, 2018
123 Views

Canopy Growth Corporation (TSX: WEED) has announced this morning that the company has completed the first phase of their partnership with Spanish company Alcaliber SA. Canopy has successfully transferred 1,500 cannabis clones to Spain for cultivation.

Canopy has transferred the 1,500 cannabis clones to Alcaliber’s Spanish cultivation facility. Under the terms of the agreement, Canopy will sell its Tweed branded products around Europe, while Alcaliber will focus on producing a variety of cannabis genetics to supply the company.  The partnership was entered into back in September 2o17.

Alcaliber SA is one of the leading pharmaceutical companies in Europe and produces 27% of the worlds morphine supply.

Canopy Growth Corporation continues its dominance of the Canadian public cannabis sector. This news marks the third continent that  will plant its clones on.

 

You may be interested

Health Canada Issues Significant Changes to Industrial Hemp Regulations
Politics
178 views
Politics
178 views

Health Canada Issues Significant Changes to Industrial Hemp Regulations

Editor - August 11, 2018

Health Canada, the overseeing body in charge of industrial hemp licensing and its regulations has just issued a new class exemption for cultivators of the plant within…

CCT150 Top 5 Banking Solutions for the Cannabis and Hemp Industries
Cash Crop 150
278 views4
Cash Crop 150
278 views4

CCT150 Top 5 Banking Solutions for the Cannabis and Hemp Industries

Editor - August 10, 2018

Federally run banking institutions have been instructed to refrain from opening bank accounts with companies involved in the cannabis and hemp industries. If they do, they could…

Canopy Growth Corp. to Conduct Clinical Trials Using CBD to Treat Anxiety in Animals
Health
313 views
Health
313 views

Canopy Growth Corp. to Conduct Clinical Trials Using CBD to Treat Anxiety in Animals

Editor - August 8, 2018

Canopy Growth Corporation (TSX: WEED) (NYSE: CGC) and its wholly owned subsidiary Canopy Health Innovations Inc. has announced this morning that they been approved by the Veterinary Drug Directorate…

Leave a Comment

Your email address will not be published.

Most from this category

%d bloggers like this: